pamidronate has been researched along with Becker Muscular Dystrophy in 3 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| " Pre-treatment with the bisphosphonate pamidronate started at 4 weeks of age over a period of 2 weeks or 6 weeks (cumulative dose 8 mg/kg for both) to assess the effectiveness of the two dosing regimens in ameliorating glucocorticoid-induced bone loss." | 1.51 | Pre-treatment with Pamidronate Improves Bone Mechanical Properties in Mdx Mice Treated with Glucocorticoids. ( Chen, J; Grynpas, MD; Mitchell, J; Yoon, SH, 2019) |
| "Pamidronate treatment protected mice from cortical bone loss but did not increase bone strength." | 1.43 | Prophylactic pamidronate partially protects from glucocorticoid-induced bone loss in the mdx mouse model of Duchenne muscular dystrophy. ( Chen, J; Grynpas, MD; Mitchell, J; Yoon, SH, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, J | 2 |
| Yoon, SH | 2 |
| Grynpas, MD | 2 |
| Mitchell, J | 2 |
| Singh, A | 1 |
| Schaeffer, EK | 1 |
| Reilly, CW | 1 |
3 other studies available for pamidronate and Becker Muscular Dystrophy
| Article | Year |
|---|---|
Pre-treatment with Pamidronate Improves Bone Mechanical Properties in Mdx Mice Treated with Glucocorticoids.
Topics: Animals; Biomechanical Phenomena; Bone and Bones; Bone Diseases, Metabolic; Cancellous Bone; Cortica | 2019 |
Vertebral Fractures in Duchenne Muscular Dystrophy Patients Managed With Deflazacort.
Topics: Adolescent; Adrenal Cortex Hormones; Bone Density; Bone Density Conservation Agents; Child; Diphosph | 2018 |
Prophylactic pamidronate partially protects from glucocorticoid-induced bone loss in the mdx mouse model of Duchenne muscular dystrophy.
Topics: Animals; Biomechanical Phenomena; Body Weight; Bone Remodeling; Bone Resorption; Calcification, Phys | 2016 |